Clinical trial
Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650
NCT00364039 · Avigen, Industry · Completed
Key facts
| NCT number | NCT00364039 |
|---|---|
| Title | Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650 |
| Official title | A Phase 1 Double-Blind, Placebo-Controlled Single Center Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Dose and Multiple Dose Escalations of AV650 in Healthy Subjects |
| Lead sponsor | Avigen, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Subjects |
| Intervention type | Drug |
| Interventions | AV650 |
| Enrollment | 30 |
| Start date | Aug 1, 2006 |
| First posted | Aug 15, 2006 |
| Last update posted | Feb 28, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: